These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 3455880)

  • 1. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
    Corin RE; Haspel HC; Peretz AM; Sonenberg M; Rifkind RA
    Cancer Res; 1986 Mar; 46(3):1136-41. PubMed ID: 3455880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
    Breitman TR; He RY
    Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of sodium butyrate from the culture medium of Friend erythroleukemia cells undergoing differentiation.
    Friend C; Zajac-Kaye M; Holland JG; Pogo BG
    Cancer Res; 1987 Jan; 47(2):378-82. PubMed ID: 3466690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
    Waxman S; Scher BM; Hellinger N; Scher W
    Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
    Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA
    Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells.
    Richon VM; Rifkind RA; Marks PA
    Cell Growth Differ; 1992 Jul; 3(7):413-20. PubMed ID: 1419904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic action of activin A and hexamethylene bisacetamide in differentiation of murine erythroleukemia cells.
    Yamashita T; Eto Y; Shibai H; Ogata E
    Cancer Res; 1990 Jun; 50(11):3182-5. PubMed ID: 2334914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in p34cdc2 kinase activity and cyclin A during induced differentiation of murine erythroleukemia cells.
    Kiyokawa H; Ngo L; Kurosaki T; Rifkind RA; Marks PA
    Cell Growth Differ; 1992 Jun; 3(6):377-83. PubMed ID: 1419901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
    Chen ZX
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dexamethasone on hexamethylene bisacetamide-induced Friend cell erythrodifferentiation.
    Osborne HB; Bakke AC; Yu J
    Cancer Res; 1982 Feb; 42(2):513-8. PubMed ID: 6173113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process.
    Chen Z; Banks J; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):471-5. PubMed ID: 6952199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
    Marks PA; Ramsay R; Sheffery M; Rifkind RA
    Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
    Marks PA; Rifkind RA
    Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrate induces expression of transfected human fetal and endogenous mouse embryonic globin genes in GM 979 erythroleukemia cells.
    Zhang JW; Raich N; Enver T; Anagnou NP; Stamatoyannopoulos G
    Dev Genet; 1990; 11(2):168-74. PubMed ID: 2379328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in electrophoretic mobility, diaphorase activity, and terminal differentiation induced in murine erythroleukemia lines by differentiating agents.
    Gascoyne PR; Becker FF
    J Cell Physiol; 1990 Feb; 142(2):309-15. PubMed ID: 2303526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.
    Fibach E; Reuben RC; Rifkind RA; Marks PA
    Cancer Res; 1977 Feb; 37(2):440-4. PubMed ID: 264411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzyl alcohol alters the hemoglobin phenotype of mouse erythroleukemia cells.
    Scher W; Scher BM; Hellinger N; Waxman S
    J Biol Regul Homeost Agents; 1989; 3(3):91-7. PubMed ID: 2483024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines.
    Langdon SP; Hawkes MM; Hay FG; Lawrie SS; Schol DJ; Hilgers J; Leonard RC; Smyth JF
    Cancer Res; 1988 Nov; 48(21):6161-5. PubMed ID: 3167862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of differentiation of human promyelocytic leukemia cells (HL60) by metabolites of hexamethylene bisacetamide.
    Snyder SW; Egorin MJ; Geelhaar LA; Hamburger AW; Callery PS
    Cancer Res; 1988 Jul; 48(13):3613-6. PubMed ID: 3163938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible effect of heme on the fate of DNA ligase activity extracted from differentiating mouse erythroleukemia cells.
    Scher BM; Scher W; Waxman S
    Cancer Res; 1988 Nov; 48(22):6278-84. PubMed ID: 3180046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.